ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681639; 2) Community: the network communities that were significantly associated with the response to NSC 681639; 3) Molecule: the relationships between components within communities and NSC 681639; 4) MDR: the compounds that were significantly associated with the NSC 681639.

NSC Compound Enrichment Correlation
NSC 179187 Salasdine 0.00970780973624031 0.18932872
NSC 313985 Gold(1+), bis(trimethylphosphine)-, chloride 0.00970780973624031 0.056575684
NSC 620256 Platinate(2-), tetrachloro-, (SP-4-1), 9-hydroxy-2,5,11- trimethyl-6H-pyrido[4,3-b]carbazolium (1:2) 0.00970780973624031 0.43688944
NSC 642282 Null 0.00970780973624031 0.61781009
NSC 665564 Null 0.00970780973624031 0.35479728
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.00970780973624031 0.22372629
NSC 166237 Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) 0.0100995289754787 0.52233046
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0100995289754787 0.64881378
NSC 357704 Cyanomorpholinodoxorubicin 0.0100995289754787 0.63374291
NSC 616348 Irinotecan hydrochloride 0.0100995289754787 0.81851637
Total:56  Current:14    [First] [Prev] [Next] [Last]